Myeloma News

CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.

CHICAGO — Sandra Mazzoni, DO, spoke with Healio about a study presented at ASCO Annual Meeting she was part of investigating the use of AI to determine any patterns in how patients with multiple myeloma respond to therapy.

CHICAGO — In this video, Sandra Mazzoni, DO, discusses the use of minimal residual disease, or MRD, testing in multiple myeloma.

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.